EXCLI Journal | 2021
COVID-19 in underlying COPD Patients
Abstract
1 Intensive Care Unit, John Hunter Hospital, Newcastle, NSW, Australia 2 Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden 3 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia 4 Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia 5 School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India 6 Aerogen, IDA Business Park, Dangan, H91 HE94, Galway, Ireland 7 School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland 8 School of Pharmacy and Pharmaceutical Sciences, Trinity College, D02 PN40 Dublin, Ireland 9 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney 2007, Australia